HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 202 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q3 2023. The put-call ratio across all filers is 0.36 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,261,383 | +206.2% | 38,492 | +205.0% | 0.00% | – |
| Q2 2023 | $412,010 | 0.0% | 12,619 | 0.0% | 0.00% | – |
| Q1 2023 | $412,010 | -76.0% | 12,619 | -59.4% | 0.00% | -100.0% |
| Q4 2022 | $1,713,611 | -99.8% | 31,100 | +25.4% | 0.00% | 0.0% |
| Q3 2022 | $1,098,038,000 | +28.0% | 24,792 | +41.0% | 0.00% | – |
| Q2 2022 | $857,523,000 | +0.2% | 17,583 | 0.0% | 0.00% | – |
| Q1 2022 | $855,412,000 | +66.8% | 17,583 | +46.2% | 0.00% | – |
| Q4 2021 | $512,704,000 | – | 12,024 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Valor Management LLC | 11,218,033 | $496,847,000 | 95.45% |
| Vivo Capital, LLC | 3,400,261 | $150,598,000 | 16.63% |
| Nan Fung Group Holdings Ltd | 510,978 | $22,631,000 | 14.44% |
| venBio Partners LLC | 1,125,673 | $49,856,000 | 11.54% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 264,500 | $11,715,000 | 3.76% |
| ASHFORD CAPITAL MANAGEMENT INC | 490,768 | $21,736,000 | 3.32% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 636,485 | $28,190,000 | 2.79% |
| Octagon Capital Advisors LP | 243,500 | $10,785,000 | 1.86% |
| TANG CAPITAL MANAGEMENT LLC | 310,000 | $13,730,000 | 1.68% |
| Lisanti Capital Growth, LLC | 248,070 | $10,987,000 | 1.47% |